FDA is a member agency in the National Nanotechnology Initiative (NNI), a federal research and development program established to coordinate the multi-agency efforts in nanoscale science, engineering, and technology. The goals of the NNI are to:
- Maintain a world-class research and development program aimed at realizing the full potential of nanotechnology;
- Facilitate transfer of new technologies into products for economic growth, jobs, and other public benefit;
- Develop educational resources, a skilled workforce, and the supporting infrastructure and tools to advance nanotechnology; and,
- Support responsible development of nanotechnology.
FDA centers are conducting nanoscale material research within programs that support their specific regulatory priorities. Participation in the NNI provides FDA and the other regulatory and research funding agencies the opportunity to define their research needs.